R. Verrijk

1.3k total citations
37 papers, 950 citations indexed

About

R. Verrijk is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, R. Verrijk has authored 37 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 8 papers in Molecular Biology and 8 papers in Pharmaceutical Science. Recurrent topics in R. Verrijk's work include Nanoparticle-Based Drug Delivery (8 papers), Advanced Drug Delivery Systems (7 papers) and Hydrogels: synthesis, properties, applications (5 papers). R. Verrijk is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Advanced Drug Delivery Systems (7 papers) and Hydrogels: synthesis, properties, applications (5 papers). R. Verrijk collaborates with scholars based in Netherlands, United States and Denmark. R. Verrijk's co-authors include Wim E. Hennink, Daan J.A. Crommelin, Wim Jiskoot, Leo G. J. de Leede, J. J. Grote, Pieter S. Hiemstra, Jan W. Drijfhout, Amon R. Wafelman, Adrian C. Begg and Gert Storm and has published in prestigious journals such as PLoS ONE, Biomaterials and Macromolecules.

In The Last Decade

R. Verrijk

36 papers receiving 926 citations

Peers

Countries citing papers authored by R. Verrijk

Since Specialization

Citations

This map shows the geographic impact of R. Verrijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Verrijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Verrijk more than expected).

Fields of papers citing papers by R. Verrijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Verrijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Verrijk. The network helps show where R. Verrijk may publish in the future.

Co-authorship network of co-authors of R. Verrijk

This figure shows the co-authorship network connecting the top 25 collaborators of R. Verrijk. A scholar is included among the top collaborators of R. Verrijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Verrijk. R. Verrijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Probabilistic modeling of an injectable aqueous crystalline suspension using influence networks 2021 ·International Journal of Pharmaceutics ·(unknown), (unknown), R. Verrijk, Thomas Rades, Jukka Rantanen	0
2	Simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level 2020 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), R. Verrijk, Thomas Rades, (unknown), Wim Jiskoot, Andrea Hawe, Jukka Rantanen	6
3	Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media 2020 ·PLoS ONE ·(unknown), (unknown), Ronald Brand, (unknown), Ewoud J. van Hoogdalem, R. Verrijk, (unknown), Amon R. Wafelman, A. Rob P.M. Valentijn, Johan H. M. Frijns, Pieter S. Hiemstra, Jan W. Drijfhout, Peter H. Nibbering, J. J. Grote	25
4	A Flow Imaging Microscopy–Based Method Using Mass-to-Volume Ratio to Derive the Porosity of PLGA Microparticles 2017 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), M. Reza Nejadnik, Miranda M. C. van Beers, (unknown), R. Verrijk, Wim Jiskoot	4
5	Determination of the Porosity of PLGA Microparticles by Tracking Their Sedimentation Velocity Using a Flow Imaging Microscope (FlowCAM) 2017 ·Pharmaceutical Research ·(unknown), (unknown), M. Reza Nejadnik, Miranda M. C. van Beers, (unknown), R. Verrijk, Wim Jiskoot	9
6	Novel Controlled-Release Lemna -Derived IFN- α 2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial 2008 ·Journal of Interferon & Cytokine Research ·Leo G. J. de Leede, John Eric Humphries, (unknown), Ewoud J. van Hoogdalem, R. Verrijk, David Spencer	51
7	Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation 2007 ·Pharmaceutical Research ·(unknown), (unknown), (unknown), C. M. Hoogerbrugge, S. C. van Buul-Offers, Leo G. J. de Leede, (unknown), Daan J.A. Crommelin, Wim E. Hennink, R. Verrijk	42
8	A mechanistic Study on the Chemical and Enzymatic Degradation of PEG‐Oligo(ε‐caprolactone) Micelles 2007 ·Journal of Pharmaceutical Sciences ·Myrra G. Carstens, Cornelus F. van Nostrum, R. Verrijk, Leo G. J. de Leede, Daan J.A. Crommelin, Wim E. Hennink	48
9	Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), M.J. van Steenbergen, R. Verrijk, Wim Jiskoot, Daan J.A. Crommelin, Wim E. Hennink	12
10	Poly(ethylene glycol)−Oligolactates with Monodisperse Hydrophobic Blocks: Preparation, Characterization, and Behavior in Water 2005 ·Langmuir ·Myrra G. Carstens, Cornelus F. van Nostrum, Aïssa Ramzi, Johannes D. Meeldijk, R. Verrijk, (unknown), Daan J.A. Crommelin, Wim E. Hennink	24
11	Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes 2003 ·Journal of Controlled Release ·Jan Hein van Steenis, Erik M. van Maarseveen, F.J. Verbaan, R. Verrijk, Daan J.A. Crommelin, G. Storm, Wim E. Hennink	95
12	Shifting paradigms: biopharmaceuticals versus low molecular weight drugs 2003 ·International Journal of Pharmaceutics ·Daan J.A. Crommelin, Gert Storm, R. Verrijk, (unknown), Wim Jiskoot, Wim E. Hennink	137
13	The effect of formulation parameters on the size of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes 1999 ·European Journal of Pharmaceutics and Biopharmaceutics ·Jong‐Yuh Cherng, H. Talsma, R. Verrijk, Daan J.A. Crommelin, Wim E. Hennink	52
14	A Comprehensive PC-based Computer Model for Microdosimetry of BNCT 1994 ·International Journal of Radiation Biology ·R. Verrijk, R. Huiskamp, Adrian C. Begg, Floyd J. Wheeler, (unknown)	11
15	Degradation and intrahepatic compatibility of albumin-heparin conjugate microspheres 1994 ·Biomaterials ·(unknown), (unknown), E.H. Blaauw, J. M. Schakenraad, Kim Hung Lam, Paul Nieuwenhuis, R. Verrijk, Glen S. Kwon, You Han Bae, Seung‐Whan Kim, Jan Feijén	6
16	Preparation and characterization of albumin-heparin microspheres 1994 ·Biomaterials ·(unknown), Glen S. Kwon, You Han Bae, (unknown), R. Verrijk, H.P.J.M. Noteborn, Jan Feijén	19
17	Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy 1994 ·British Journal of Cancer ·R. Verrijk, (unknown), R. Huiskamp, Patrick R. Gavin, (unknown), Adrian C. Begg	2
18	Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin 1991 ·Cancer Chemotherapy and Pharmacology ·R. Verrijk, (unknown), J. Gordon McVie, Adrian C. Begg	25
19	Plasma Elimination of Milrinone in Rats in Relation to Its Hemodynamic Effects 1990 ·Journal of Pharmaceutical Sciences ·R. Verrijk, W. Vleeming, (unknown), Johan Wemer, A. J. Porsius	8
20	Drug delivery systems. 1989 ·PubMed ·(unknown), R. Verrijk	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact